Multicenter evaluation of the cepheid xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares

D. M. Wolk, E. Picton, D. Johnson, Thomas Davis, P. Pancholi, C. C. Ginocchio, S. Finegold, D. F. Welch, M. De Boer, D. Fuller, M. C. Solomon, B. Rogers, M. S. Mehta, L. R. Peterson

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

The first U.S. multicenter clinical trial to assess the performance of the Cepheid Xpert MRSA assay (Xpert MRSA) was conducted. The assay is a qualitative test designed for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) directly from nares swabs. This novel test combines integrated nucleic acid extraction and automated real-time PCR for the detection of a MRSA-specific signature sequence. A total of 1,077 nares specimens were collected from seven geographically distinct health care sites across the United States with prevalence rates ranging from 5.2% to 44%. Nares specimens were tested by (i) the Xpert MRSA assay, (ii) direct culture on CHROMagar MRSA medium (direct CM culture), and (iii) broth-enriched culture (Trypticase soy broth with 6.5% sodium chloride) followed by plating onto CHROMagar MRSA medium (broth-enriched CM culture). When direct CM culture was designated the reference method, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Xpert MRSA assay were 94.3%, 93.2%, 73.0%, and 98.8%, respectively. When broth-enriched CM culture was used as the reference method, the clinical sensitivity, specificity, PPV, and NPV of the Xpert MRSA assay were 86.3%, 94.9%, 80.5%, and 96.6%, respectively. The BD GeneOhm MRSA (BDGO) assay was performed as a comparative molecular method. No statistical performance differences were observed between the Xpert MRSA and BDGO assays when they were compared to culture methods. From this large-scale, multicenter clinical comparison, we conclude that the Xpert MRSA assay is a simple, rapid, and accurate method for performing active surveillance for MRSA in a variety of health care populations.

Original languageEnglish
Pages (from-to)758-764
Number of pages7
JournalJournal of Clinical Microbiology
Volume47
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Delivery of Health Care
Sensitivity and Specificity
Sodium Chloride
Nucleic Acids
Multicenter Studies
Real-Time Polymerase Chain Reaction

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Multicenter evaluation of the cepheid xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. / Wolk, D. M.; Picton, E.; Johnson, D.; Davis, Thomas; Pancholi, P.; Ginocchio, C. C.; Finegold, S.; Welch, D. F.; De Boer, M.; Fuller, D.; Solomon, M. C.; Rogers, B.; Mehta, M. S.; Peterson, L. R.

In: Journal of Clinical Microbiology, Vol. 47, No. 3, 03.2009, p. 758-764.

Research output: Contribution to journalArticle

Wolk, DM, Picton, E, Johnson, D, Davis, T, Pancholi, P, Ginocchio, CC, Finegold, S, Welch, DF, De Boer, M, Fuller, D, Solomon, MC, Rogers, B, Mehta, MS & Peterson, LR 2009, 'Multicenter evaluation of the cepheid xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares', Journal of Clinical Microbiology, vol. 47, no. 3, pp. 758-764. https://doi.org/10.1128/JCM.01714-08
Wolk, D. M. ; Picton, E. ; Johnson, D. ; Davis, Thomas ; Pancholi, P. ; Ginocchio, C. C. ; Finegold, S. ; Welch, D. F. ; De Boer, M. ; Fuller, D. ; Solomon, M. C. ; Rogers, B. ; Mehta, M. S. ; Peterson, L. R. / Multicenter evaluation of the cepheid xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. In: Journal of Clinical Microbiology. 2009 ; Vol. 47, No. 3. pp. 758-764.
@article{1b605905b7fa458c95412fdc457906a7,
title = "Multicenter evaluation of the cepheid xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares",
abstract = "The first U.S. multicenter clinical trial to assess the performance of the Cepheid Xpert MRSA assay (Xpert MRSA) was conducted. The assay is a qualitative test designed for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) directly from nares swabs. This novel test combines integrated nucleic acid extraction and automated real-time PCR for the detection of a MRSA-specific signature sequence. A total of 1,077 nares specimens were collected from seven geographically distinct health care sites across the United States with prevalence rates ranging from 5.2{\%} to 44{\%}. Nares specimens were tested by (i) the Xpert MRSA assay, (ii) direct culture on CHROMagar MRSA medium (direct CM culture), and (iii) broth-enriched culture (Trypticase soy broth with 6.5{\%} sodium chloride) followed by plating onto CHROMagar MRSA medium (broth-enriched CM culture). When direct CM culture was designated the reference method, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Xpert MRSA assay were 94.3{\%}, 93.2{\%}, 73.0{\%}, and 98.8{\%}, respectively. When broth-enriched CM culture was used as the reference method, the clinical sensitivity, specificity, PPV, and NPV of the Xpert MRSA assay were 86.3{\%}, 94.9{\%}, 80.5{\%}, and 96.6{\%}, respectively. The BD GeneOhm MRSA (BDGO) assay was performed as a comparative molecular method. No statistical performance differences were observed between the Xpert MRSA and BDGO assays when they were compared to culture methods. From this large-scale, multicenter clinical comparison, we conclude that the Xpert MRSA assay is a simple, rapid, and accurate method for performing active surveillance for MRSA in a variety of health care populations.",
author = "Wolk, {D. M.} and E. Picton and D. Johnson and Thomas Davis and P. Pancholi and Ginocchio, {C. C.} and S. Finegold and Welch, {D. F.} and {De Boer}, M. and D. Fuller and Solomon, {M. C.} and B. Rogers and Mehta, {M. S.} and Peterson, {L. R.}",
year = "2009",
month = "3",
doi = "10.1128/JCM.01714-08",
language = "English",
volume = "47",
pages = "758--764",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Multicenter evaluation of the cepheid xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares

AU - Wolk, D. M.

AU - Picton, E.

AU - Johnson, D.

AU - Davis, Thomas

AU - Pancholi, P.

AU - Ginocchio, C. C.

AU - Finegold, S.

AU - Welch, D. F.

AU - De Boer, M.

AU - Fuller, D.

AU - Solomon, M. C.

AU - Rogers, B.

AU - Mehta, M. S.

AU - Peterson, L. R.

PY - 2009/3

Y1 - 2009/3

N2 - The first U.S. multicenter clinical trial to assess the performance of the Cepheid Xpert MRSA assay (Xpert MRSA) was conducted. The assay is a qualitative test designed for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) directly from nares swabs. This novel test combines integrated nucleic acid extraction and automated real-time PCR for the detection of a MRSA-specific signature sequence. A total of 1,077 nares specimens were collected from seven geographically distinct health care sites across the United States with prevalence rates ranging from 5.2% to 44%. Nares specimens were tested by (i) the Xpert MRSA assay, (ii) direct culture on CHROMagar MRSA medium (direct CM culture), and (iii) broth-enriched culture (Trypticase soy broth with 6.5% sodium chloride) followed by plating onto CHROMagar MRSA medium (broth-enriched CM culture). When direct CM culture was designated the reference method, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Xpert MRSA assay were 94.3%, 93.2%, 73.0%, and 98.8%, respectively. When broth-enriched CM culture was used as the reference method, the clinical sensitivity, specificity, PPV, and NPV of the Xpert MRSA assay were 86.3%, 94.9%, 80.5%, and 96.6%, respectively. The BD GeneOhm MRSA (BDGO) assay was performed as a comparative molecular method. No statistical performance differences were observed between the Xpert MRSA and BDGO assays when they were compared to culture methods. From this large-scale, multicenter clinical comparison, we conclude that the Xpert MRSA assay is a simple, rapid, and accurate method for performing active surveillance for MRSA in a variety of health care populations.

AB - The first U.S. multicenter clinical trial to assess the performance of the Cepheid Xpert MRSA assay (Xpert MRSA) was conducted. The assay is a qualitative test designed for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) directly from nares swabs. This novel test combines integrated nucleic acid extraction and automated real-time PCR for the detection of a MRSA-specific signature sequence. A total of 1,077 nares specimens were collected from seven geographically distinct health care sites across the United States with prevalence rates ranging from 5.2% to 44%. Nares specimens were tested by (i) the Xpert MRSA assay, (ii) direct culture on CHROMagar MRSA medium (direct CM culture), and (iii) broth-enriched culture (Trypticase soy broth with 6.5% sodium chloride) followed by plating onto CHROMagar MRSA medium (broth-enriched CM culture). When direct CM culture was designated the reference method, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Xpert MRSA assay were 94.3%, 93.2%, 73.0%, and 98.8%, respectively. When broth-enriched CM culture was used as the reference method, the clinical sensitivity, specificity, PPV, and NPV of the Xpert MRSA assay were 86.3%, 94.9%, 80.5%, and 96.6%, respectively. The BD GeneOhm MRSA (BDGO) assay was performed as a comparative molecular method. No statistical performance differences were observed between the Xpert MRSA and BDGO assays when they were compared to culture methods. From this large-scale, multicenter clinical comparison, we conclude that the Xpert MRSA assay is a simple, rapid, and accurate method for performing active surveillance for MRSA in a variety of health care populations.

UR - http://www.scopus.com/inward/record.url?scp=62749097995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62749097995&partnerID=8YFLogxK

U2 - 10.1128/JCM.01714-08

DO - 10.1128/JCM.01714-08

M3 - Article

C2 - 19129414

AN - SCOPUS:62749097995

VL - 47

SP - 758

EP - 764

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -